Prognostic significance of tyrosinase mRNA detected by nested RT-PCR in patients with malignant melanoma

Neoplasma

Volumn 53, Issue 1, 2006, Pages 9-14

  Glumac, N ^a   Snoj, M ^a   Hocevar, M ^a   Novakovic, S ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Malignant melanoma; mRNA; Nested RT PCR; Tyrosinase

Indexed keywords

MESSENGER RNA; MONOPHENOL MONOOXYGENASE;

ADULT; ADVANCED CANCER; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LOG RANK TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PERIPHERAL VEIN; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; VENOUS BLOOD;

EID: 32144452923     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. BALCH CM, SOONG SJ, GERSHENWALD JE, THOMPSON JF, REINTGEN DS et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19: 3622-3634.
2. BALCH CM, BUZAID AC, SOONG SJ, ATKINS MB, CASCINELLI N et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635-3648.
3. GARBE C, LEITER U, ELLWANGER U, BLAHETA HJ, MEIER F et al. Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients. Cancer 2003; 97: 1737-1745.
4. MCMASTERS KM. The Sunbelt Melanoma Trial. Ann Surg Oncol 2001; 8: 41S-43S.
5. SZENAJCH J, JASINSKI B, SYNOWIEC A, KULIK J, CHOMICKA M et al. Prognostic value of multiple reverse transcription-PCR tyrosinase testing for circulating neoplastic cells in malignant melanoma. Clin Chem 2003; 49: 1450-1457.
6. SMITH B, SELBY P, SOUTHGATE J, PITTMAN K, BRADLEY C et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991; 338: 1227-1229.
7. KWON BS. Pigmentation genes: the tyrosinase gene family and the pmel 17 gene family. J Invest Dermatol 1993; 100: 134S-140S.
8. GLUMAC N, HOCEVAR M, SNOJ M, NOVAKOVIC S. Detection of tyrosinase mRNA by an optimised nested RT-PCR in the peripheral blood of patients with advanced malignant melanoma. J Exp Clin Cancer Res 2001; 20: 529-536.
9. TSAO H, NADIMINTI U, SOBER AJ, BIGBY M. A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma. Arch Dermatol 2001; 137: 325-330.
10. BATTAYANI Z, GROB JJ, XERRI L, NOE C, ZAROUR H et al. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 1995; 131: 443-447.
11. FARTHMANN B, EBERLE J, KRASAGAKIS K, GSTOTTNER M, WANG N et al. RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients. J Invest Dermatol 1998; 110: 263-267.
12. GHOSSEIN RA, COIT D, BRENNAN M, ZHANG ZF, WANG Y et al. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Clin Cancer Res 1998; 4: 419-428.
13. HOON DS, WANG Y, DALE PS, CONRAD AJ, SCHMID P et al. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 1995; 13: 2109-2116.
14. KUNTER U, BUER J, PROBST M, DUENSING S, DALLMANN I et al. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 1996; 88: 590-594.
15. MELLADO B, COLOMER D, CASTEL T, MUNOZ M, CARBALLO E et al. Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J Clin Oncol 1996; 14: 2091-2097.
16. MELLADO B, GUTIERREZ L, CASTEL T, COLOMER D, FONTANILLAS M et al. Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients. Clin Cancer Res 1999; 5: 1843-1848.
17. PROEBSTLE TM, JIANG W, HOGEL J, KEILHOLZ U, WEBER L et al. Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors. Br J Cancer 2000; 82: 118-123.
18. HANEKOM GS, STUBBINGS HM, JOHNSON CA, KIDSON SH. The detection of circulating melanoma cells correlates with tumour thickness and ulceration but is not predictive of metastasis for patients with primary melanoma. Melanoma Res 1999; 9: 465-473.
19. REINHOLD U, LUDTKE-HANDJERY HC, SCHNAUTZ S, KREYSEL HW, ABKEN H. The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression. J Invest Dermatol 1997; 108: 166-169.
20. CHOMCZYNSKI P, SACCHI N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
21. KAPLAN EL, MEIER P. Non-parametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
22. PRICHARD RS, DIJKSTRA B, MCDERMOTT EW, HILL AD, O'HIGGINS NJ. The role of molecular staging in malignant melanoma. Eur J Surg Oncol 2003; 29: 306-314.
23. FOSS AJ, GUILLE MJ, OCCLESTON NL, HYKIN PG, HUNGERFORD JL et al. The detection of melanoma cells in peripheral blood by reverse transcription- polymerase chain reaction. Br J Cancer 1995; 72: 155-159.
24. RYAN L, KRAMAR A, BORDEN E. Prognostic factors in metastatic melanoma. Cancer 1993; 71: 2995-3005.
25. SINKOVICS JG, HORVATH JC. Vaccination against human cancers (review). Int J Oncol 2000; 16: 81-96.
26. NOVAKOVIC S, CEGOVNIK U, MENART V, GALVANI V, WRABER B. Construction of an expression cassette with hTNF-alpha gene for transient expression of the gene in mammalian cells. Anticancer Res 2001; 21: 365-371.
27. SAVOIA P, QUAGLINO P, OSELLA-ABATE S, COMESSATTI A, NARDO T et al. Tyrosinase mRNA RT-PCR analysis as an additional diagnostic tool for the identification of melanoma cells in biological fluid samples other than blood: a preliminary report. Int J Biol Markers 2005; 20: 11-17.